IER5 can competitively bind the Cdc25B promoter, inhibiting the interaction between the transcription factor NF-YB and Cdc25B, thereby inhibiting Cdc25B transcription and reducing Cdc25B expression in acute myeloid leukemia [16]. The gene discussed is CDC25B; the disease is acute myeloid leukemia.